PharMerica shareholders approve merger
PharMerica Corporation said this week the majority of outstanding shares of PharMerica common stock voted to approve the adoption a merger.
The $1.4 billion deal with global investment firm KKR includes Walgreens Boots Alliance Inc. as a minority investor. The company said more than 99% of votes cast were cast in favor of the merger agreement.
The deal was first announced in August.